Literature DB >> 23258471

[Genetic variants of alpha-1 antitrypsin: classification and clinical implications].

Beata Popławska1, Sabina Janciauskiene, Joanna Chorostowska-Wynimko.   

Abstract

Inherited alpha-1 antitrypsin deficiency is listed among the three most common genetic disorders in Caucasians. It considerably increases the risk of progressive obstructive lung diseases, mostly chronic obstructive pulmonary disease, as well as chronic liver disorders, hepatitis, cirrhosis, and cancer. It is estimated that more than 5.5% of the Polish population carries one of the most common deficiency phenotypes, which might be relatively easily detected due to low alpha-1 antitrypsin serum concentration. However, as well as being quantitative, alpha-1 antitrypsin deficiency might also be qualitative. These dysfunctional alpha-1 antitrypsin variants are characterized by scarce antiproteolytic activity and quite often by fully effective protein production resulting in normal serum levels. Consequently, dysfunctional variant identification is possible only by means of pheno- or genotyping. This review presents clinically useful characteristics of main genetic alpha-1 antitrypsin variants.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23258471

Source DB:  PubMed          Journal:  Pneumonol Alergol Pol        ISSN: 0867-7077


  5 in total

Review 1.  Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy.

Authors:  Joanna Wozniak; Tomasz Wandtke; Piotr Kopinski; Joanna Chorostowska-Wynimko
Journal:  Hum Gene Ther       Date:  2015-09-29       Impact factor: 5.695

2.  How Can We Improve the Detection of Alpha1-Antitrypsin Deficiency?

Authors:  Ilaria Ferrarotti; Beata Poplawska-Wisniewska; Maria Teresa Trevisan; Janine Koepke; Marc Dresel; Rembert Koczulla; Stefania Ottaviani; Raffaele Baldo; Marina Gorrini; Giorgia Sala; Luana Cavallon; Tobias Welte; Joanna Chorostowska-Wynimko; Maurizio Luisetti; Sabina Janciauskiene
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

3.  Selected metabolic aspects of elastin and collagen fiber proteolysis in diseases of the respiratory system - the significance of α1 antitrypsin deficiency.

Authors:  Agata Dżeljilji; Wojciech Rokicki; Krzysztof Karuś
Journal:  Kardiochir Torakochirurgia Pol       Date:  2016-09-30

4.  The Diagnostic Value of Alpha-1-Antitrypsin Phenotype in Patients with Granulomatosis with Polyangiitis.

Authors:  M Y Pervakova; V L Emanuel; O N Titova; S V Lapin; V I Mazurov; I B Belyaeva; A L Chudinov; T V Blinova; E A Surkova
Journal:  Int J Rheumatol       Date:  2016-04-10

Review 5.  The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals.

Authors:  Danielle M Dunlea; Laura T Fee; Thomas McEnery; Noel G McElvaney; Emer P Reeves
Journal:  J Inflamm Res       Date:  2018-03-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.